Logo image of CSL

CARLISLE COS INC (CSL) Stock Fundamental Analysis

NYSE:CSL - New York Stock Exchange, Inc. - US1423391002 - Common Stock - Currency: USD

386.84  -2.63 (-0.68%)

After market: 386.84 0 (0%)

Fundamental Rating

7

Overall CSL gets a fundamental rating of 7 out of 10. We evaluated CSL against 42 industry peers in the Building Products industry. CSL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CSL has a decent growth rate and is not valued too expensively. These ratings would make CSL suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CSL had positive earnings in the past year.
In the past year CSL had a positive cash flow from operations.
In the past 5 years CSL has always been profitable.
In the past 5 years CSL always reported a positive cash flow from operatings.
CSL Yearly Net Income VS EBIT VS OCF VS FCFCSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of CSL (23.13%) is better than 97.62% of its industry peers.
With an excellent Return On Equity value of 58.19%, CSL belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
CSL's Return On Invested Capital of 17.59% is amongst the best of the industry. CSL outperforms 80.95% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSL is above the industry average of 12.98%.
The 3 year average ROIC (15.62%) for CSL is below the current ROIC(17.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.13%
ROE 58.19%
ROIC 17.59%
ROA(3y)15.61%
ROA(5y)11.62%
ROE(3y)36.9%
ROE(5y)27.85%
ROIC(3y)15.62%
ROIC(5y)12.39%
CSL Yearly ROA, ROE, ROICCSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CSL has a Profit Margin of 25.20%. This is amongst the best in the industry. CSL outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of CSL has grown nicely.
CSL's Operating Margin of 22.02% is amongst the best of the industry. CSL outperforms 92.86% of its industry peers.
In the last couple of years the Operating Margin of CSL has grown nicely.
CSL has a Gross Margin of 37.47%. This is in the better half of the industry: CSL outperforms 64.29% of its industry peers.
In the last couple of years the Gross Margin of CSL has grown nicely.
Industry RankSector Rank
OM 22.02%
PM (TTM) 25.2%
GM 37.47%
OM growth 3Y14.04%
OM growth 5Y10.94%
PM growth 3Y33.65%
PM growth 5Y21.71%
GM growth 3Y9.73%
GM growth 5Y5.76%
CSL Yearly Profit, Operating, Gross MarginsCSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CSL is creating value.
The number of shares outstanding for CSL has been reduced compared to 1 year ago.
The number of shares outstanding for CSL has been reduced compared to 5 years ago.
CSL has a better debt/assets ratio than last year.
CSL Yearly Shares OutstandingCSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSL Yearly Total Debt VS Total AssetsCSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 6.63 indicates that CSL is not in any danger for bankruptcy at the moment.
CSL has a better Altman-Z score (6.63) than 76.19% of its industry peers.
CSL has a debt to FCF ratio of 2.49. This is a good value and a sign of high solvency as CSL would need 2.49 years to pay back of all of its debts.
CSL has a better Debt to FCF ratio (2.49) than 69.05% of its industry peers.
A Debt/Equity ratio of 0.87 indicates that CSL is somewhat dependend on debt financing.
The Debt to Equity ratio of CSL (0.87) is worse than 71.43% of its industry peers.
Even though the debt/equity ratio score it not favorable for CSL, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 2.49
Altman-Z 6.63
ROIC/WACC1.84
WACC9.55%
CSL Yearly LT Debt VS Equity VS FCFCSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

CSL has a Current Ratio of 2.58. This indicates that CSL is financially healthy and has no problem in meeting its short term obligations.
CSL has a Current ratio of 2.58. This is in the better half of the industry: CSL outperforms 69.05% of its industry peers.
CSL has a Quick Ratio of 1.69. This is a normal value and indicates that CSL is financially healthy and should not expect problems in meeting its short term obligations.
CSL's Quick ratio of 1.69 is fine compared to the rest of the industry. CSL outperforms 69.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.69
CSL Yearly Current Assets VS Current LiabilitesCSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.24% over the past year.
CSL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.74% yearly.
CSL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.97%.
Measured over the past years, CSL shows a small growth in Revenue. The Revenue has been growing by 0.79% on average per year.
EPS 1Y (TTM)13.24%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%-2.96%
Revenue 1Y (TTM)-11.97%
Revenue growth 3Y9.26%
Revenue growth 5Y0.79%
Sales Q2Q%-0.06%

3.2 Future

CSL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.19% yearly.
The Revenue is expected to grow by 4.85% on average over the next years.
EPS Next Y10.44%
EPS Next 2Y11.88%
EPS Next 3Y12.19%
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2Y4.15%
Revenue Next 3Y4.85%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CSL Yearly Revenue VS EstimatesCSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CSL Yearly EPS VS EstimatesCSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.25, the valuation of CSL can be described as rather expensive.
CSL's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 25.82. CSL is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 15.29, which indicates a correct valuation of CSL.
CSL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CSL is cheaper than 61.90% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CSL is valued a bit cheaper.
Industry RankSector Rank
PE 19.25
Fwd PE 15.29
CSL Price Earnings VS Forward Price EarningsCSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CSL's Enterprise Value to EBITDA ratio is in line with the industry average.
CSL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 22.05
EV/EBITDA 14.43
CSL Per share dataCSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CSL has an outstanding profitability rating, which may justify a higher PE ratio.
CSL's earnings are expected to grow with 12.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.84
PEG (5Y)0.97
EPS Next 2Y11.88%
EPS Next 3Y12.19%

5

5. Dividend

5.1 Amount

CSL has a yearly dividend return of 1.00%, which is pretty low.
CSL's Dividend Yield is a higher than the industry average which is at 1.16.
Compared to an average S&P500 Dividend Yield of 2.36, CSL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1%

5.2 History

On average, the dividend of CSL grows each year by 15.64%, which is quite nice.
CSL has been paying a dividend for at least 10 years, so it has a reliable track record.
CSL has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.64%
Div Incr Years34
Div Non Decr Years34
CSL Yearly Dividends per shareCSL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

CSL pays out 13.97% of its income as dividend. This is a sustainable payout ratio.
CSL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP13.97%
EPS Next 2Y11.88%
EPS Next 3Y12.19%
CSL Yearly Income VS Free CF VS DividendCSL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CSL Dividend Payout.CSL Dividend Payout, showing the Payout Ratio.CSL Dividend Payout.PayoutRetained Earnings

CARLISLE COS INC

NYSE:CSL (5/23/2025, 8:04:01 PM)

After market: 386.84 0 (0%)

386.84

-2.63 (-0.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-22 2025-07-22/amc
Inst Owners92.38%
Inst Owner Change3.73%
Ins Owners0.84%
Ins Owner Change6.9%
Market Cap16.73B
Analysts78.33
Price Target448.8 (16.02%)
Short Float %5.2%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield 1%
Yearly Dividend3.74
Dividend Growth(5Y)15.64%
DP13.97%
Div Incr Years34
Div Non Decr Years34
Ex-Date05-19 2025-05-19 (1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.39%
Min EPS beat(2)0.14%
Max EPS beat(2)4.64%
EPS beat(4)3
Avg EPS beat(4)1.67%
Min EPS beat(4)-1.66%
Max EPS beat(4)4.64%
EPS beat(8)7
Avg EPS beat(8)8.31%
EPS beat(12)10
Avg EPS beat(12)7.7%
EPS beat(16)14
Avg EPS beat(16)10.63%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-0.38%
Revenue beat(4)0
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)-0.38%
Revenue beat(8)2
Avg Revenue beat(8)-0.33%
Revenue beat(12)3
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)1.29%
PT rev (1m)-2.22%
PT rev (3m)-7.04%
EPS NQ rev (1m)-4.01%
EPS NQ rev (3m)-4.62%
EPS NY rev (1m)0.3%
EPS NY rev (3m)-1.37%
Revenue NQ rev (1m)-1.18%
Revenue NQ rev (3m)-1.18%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 19.25
Fwd PE 15.29
P/S 3.34
P/FCF 22.05
P/OCF 19.26
P/B 7.72
P/tB N/A
EV/EBITDA 14.43
EPS(TTM)20.1
EY5.2%
EPS(NY)25.3
Fwd EY6.54%
FCF(TTM)17.54
FCFY4.54%
OCF(TTM)20.08
OCFY5.19%
SpS115.67
BVpS50.09
TBVpS-18.95
PEG (NY)1.84
PEG (5Y)0.97
Profitability
Industry RankSector Rank
ROA 23.13%
ROE 58.19%
ROCE 22.67%
ROIC 17.59%
ROICexc 18.42%
ROICexgc 51.74%
OM 22.02%
PM (TTM) 25.2%
GM 37.47%
FCFM 15.17%
ROA(3y)15.61%
ROA(5y)11.62%
ROE(3y)36.9%
ROE(5y)27.85%
ROIC(3y)15.62%
ROIC(5y)12.39%
ROICexc(3y)17.52%
ROICexc(5y)13.93%
ROICexgc(3y)50.21%
ROICexgc(5y)41.16%
ROCE(3y)20.13%
ROCE(5y)15.97%
ROICexcg growth 3Y28.32%
ROICexcg growth 5Y11.4%
ROICexc growth 3Y36.27%
ROICexc growth 5Y11.03%
OM growth 3Y14.04%
OM growth 5Y10.94%
PM growth 3Y33.65%
PM growth 5Y21.71%
GM growth 3Y9.73%
GM growth 5Y5.76%
F-Score6
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 2.49
Debt/EBITDA 1.47
Cap/Depr 60.5%
Cap/Sales 2.19%
Interest Coverage 250
Cash Conversion 67.7%
Profit Quality 60.19%
Current Ratio 2.58
Quick Ratio 1.69
Altman-Z 6.63
F-Score6
WACC9.55%
ROIC/WACC1.84
Cap/Depr(3y)69.38%
Cap/Depr(5y)62.06%
Cap/Sales(3y)2.91%
Cap/Sales(5y)2.9%
Profit Quality(3y)99.02%
Profit Quality(5y)110.75%
High Growth Momentum
Growth
EPS 1Y (TTM)13.24%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%-2.96%
EPS Next Y10.44%
EPS Next 2Y11.88%
EPS Next 3Y12.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.97%
Revenue growth 3Y9.26%
Revenue growth 5Y0.79%
Sales Q2Q%-0.06%
Revenue Next Year3.68%
Revenue Next 2Y4.15%
Revenue Next 3Y4.85%
Revenue Next 5YN/A
EBIT growth 1Y-8.82%
EBIT growth 3Y24.59%
EBIT growth 5Y11.81%
EBIT Next Year21.41%
EBIT Next 3Y12.82%
EBIT Next 5YN/A
FCF growth 1Y-16.94%
FCF growth 3Y47.3%
FCF growth 5Y8.35%
OCF growth 1Y-21.48%
OCF growth 3Y34.69%
OCF growth 5Y7.94%